CURAXIS PHARMACEUTICAL CORP Increase (Decrease) in Accounts Payable
CURAXIS PHARMACEUTICAL CORP reported Increase (Decrease) in Accounts Payable of $34.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2012-05-14
- CURAXIS PHARMACEUTICAL CORP increase (decrease) in accounts payable for the quarter ending 2012-03-31 was $34.00K, a 32.00% decline year-over-year.
- CURAXIS PHARMACEUTICAL CORP increase (decrease) in accounts payable for the quarter ending 2011-12-31 was $130.00K, a 41.18% decline year-over-year.
- CURAXIS PHARMACEUTICAL CORP increase (decrease) in accounts payable for the quarter ending 2011-09-30 was $76.00K.
- CURAXIS PHARMACEUTICAL CORP increase (decrease) in accounts payable for the quarter ending 2011-06-30 was $157.00K.
- CURAXIS PHARMACEUTICAL CORP increase (decrease) in accounts payable for fiscal 2011 was $413.00K, a 95.73% increase from fiscal 2010.
- CURAXIS PHARMACEUTICAL CORP increase (decrease) in accounts payable for fiscal 2010 was $211.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 41 month | Increase (Decrease) in Accounts Payable 127 month | Increase (Decrease) in Accounts Payable 130 month | Increase (Decrease) in Accounts Payable 133 month |
|---|---|---|---|---|---|---|---|---|
| 2012-03-31 | $34.00K 10-Q · filed 2012-05-14 | $164.00K derived: sum of 2 quarters · filed 2012-05-14 | $240.00K derived: sum of 3 quarters · filed 2012-05-14 | $397.00K derived: sum of 4 quarters · filed 2012-05-14 | $8.18M 10-Q · filed 2012-05-14 | |||
| 2011-12-31 | $130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $206.00K derived: sum of 2 quarters · filed 2012-03-29 | $363.00K derived: sum of 3 quarters · filed 2012-03-29 | $413.00K 10-K · filed 2012-03-29 | $8.15M 10-K · filed 2012-03-29 | |||
| 2011-09-30 | $76.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $233.00K derived: sum of 2 quarters · filed 2011-11-10 | $283.00K 10-Q · filed 2011-11-10 | $504.00K derived: sum of 4 quarters · filed 2012-05-14 | $8.02M 10-Q · filed 2011-11-10 | |||
| 2011-06-30 | $157.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-12 | $207.00K 10-Q · filed 2011-08-12 | $428.00K derived: sum of 3 quarters · filed 2012-05-14 | $401.00K derived: sum of 4 quarters · filed 2012-05-14 | $7.94M 10-Q · filed 2011-08-12 | |||
| 2011-03-31 | $50.00K 10-Q · filed 2012-05-14 | $271.00K derived: sum of 2 quarters · filed 2012-05-14 | $244.00K derived: sum of 3 quarters · filed 2012-05-14 | |||||
| 2010-12-31 | $221.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $194.00K derived: sum of 2 quarters · filed 2012-03-29 | $211.00K 10-K · filed 2012-03-29 | |||||
| 2010-09-30 | -$27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | -$10.00K 10-Q · filed 2011-11-10 | ||||||
| 2010-06-30 | $17.00K 10-Q · filed 2011-08-12 |